Australia TGA ARTG recordNeuroStimulator PENS therapy® Device - Analgesic PENS system
Australia TGA ARTG Registered Device · Algostim Research & Development Pty Limited · Algotec Research and Development Ltd · Class IIa · Started July 23, 2014
Good Name: Algostim Research & Development Pty Limited - NeuroStimulator PENS therapy® Device - Analgesic PENS system
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- July 23, 2014
- Effective Date
- July 23, 2014
- Country
- United Kingdom
- Address
- Basepoint Business Centre John de Mierre House Bridge Rd, Haywards Heath, West Sussex, RH16 1UA
The NeuroStimulator PENS therapy pain management system is intended for selectively stimulating peripheral nerves, for the symptomatic relief of chronic peripheral neuropathic pain, as determined by a suitably qualified pain management physician in a clinical setting only. Stimulation is typically delivered for between 2 and 25 minutes and repeated if required or indicated by the physician.
Access comprehensive regulatory information for NeuroStimulator PENS therapy® Device - Analgesic PENS system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Algostim Research & Development Pty Limited, manufactured by Algotec Research and Development Ltd in United Kingdom. The device registration started on July 23, 2014.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.